GL CHEMTEC INTERNATIONAL (GLC) is a progressive chemistry organization dedicated to custom synthesis and contract research. GLC primarily serves the pharmaceutical, biotechnology, electronics, ophthalmic, and medical device sectors. We provide our valued clients with transparent and flexible chemistry services tailored to their individual research needs. We place extreme importance on tight deadlines, effective communication, accountability, maintaining high levels of confidentiality, and providing high quality materials. GLC was founded in 2002 and remains private and self-funded. Our focus has traditionally been on the synthesis and design of novel small molecules and intermediates (building blocks), pre-clinical compounds, synthetic route development and optimization, complex chemistry and polymers, air-sensitive chemistry, and analogue chemistry (library synthesis). We offer in-house scale-up to 25 kg batches. Our mission has always been to create an atmosphere of mutual respect where our scientists can contribute to society in a positive way. In this fashion, our clients will receive the expertise and attention to detail that they deserve and expect from their contract research partner. Our goal is to reduce client’s time to market and pre-clinical chemistry costs by offering competitive FTE rates. GL CHEMTEC INTERNATIONAL has developed expertise in the following therapeutic areas: Oncology Central Nervous System HIV/AIDS Cardiovascular & Metabolic Disease Anti-Psychotics Gastrointestinal Conditions Inflammation Anti-Infectives/Anti-Virals Alzheimers GLC is proud to be a new technology and materials provider to the Ophthalmic and Medical Device industries. We have a strong track-record of providing new monomers, polymers, and technologies for application in the eye care sector. Our expertise in organic, organometallic, and polymer chemistry has allowed us to rapidly expand the growth of these innovative service offerings over the last five years. In addition, GLC has developed a line of proprietary new materials in this area, focused on conventional hydrogel and silicone hydrogel polymers.

Registered Capital:  

Registered Address:  

Company Type:  MPR

Business Scope: